Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure.
暂无分享,去创建一个
W. Siegert | H. Heimpel | A. Zander | J. Finke | A. Gratwohl | A. Tobler | D. Hossfeld | E. Holler | G. Ehninger | R. Hehlmann | A. Hochhaus | C. Nerl | U. Berger | H. Kolb | J. Hasford | H. Pralle | H. Löffler | A. Heyll | M. Pfirrmann | A. Fauser | W. Queisser | A. Muth